+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Osteoarthritis Drug"

From
From
From
From
From
From
From
JOYCLU Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JOYCLU Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
CARTISTEM Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CARTISTEM Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
From
Osteoarthritis Therapeutics Market 2024-2028 - Product Thumbnail Image

Osteoarthritis Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 177 Pages
  • Global
From
Loading Indicator

The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs). The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more